OrganOx
OrganOx is a medical technology company, based in Oxford, UK, that has developed metra, a revolutionary device for storing livers at normal body temperatures for extended periods of time, which is commercially available within the EU.
OrganOx was founded in 2008 to exploit technology invented by Professor Peter Friend and colleagues and further developed by Professor Constantin Coussios at the University of Oxford. The normothermic liver perfusion device that has been developed is transforming liver transplantation.
OrganOx is engaged in a further pivotal study in the US and a further study at the Queen Elizabeth Hospital, Birmingham to test the viability and transplant potential of marginal livers.
Amadeus contact
In the media
7th July 2020
Jewish Market Reports
for this study are PARAGONIX TECHNOLOGIES INC., 21st Century Medicine, ESSENTIAL PHARMACEUTICALS LLC, Lifeline Scientific, Dr. Franz Köhler Chemie GmbH, Preservation Solutions Inc, OrganOx Limited, XVIVO Perfusion. Market Analysis and Insights
7th July 2020
Jewish Market Reports
for this study are PARAGONIX TECHNOLOGIES INC., 21st Century Medicine, ESSENTIAL PHARMACEUTICALS LLC, Lifeline Scientific, Dr. Franz Köhler Chemie GmbH, Preservation Solutions Inc, OrganOx Limited, XVIVO Perfusion. Market Analysis and Insights
7th July 2020
Jewish Market Reports
for this study are PARAGONIX TECHNOLOGIES INC., 21st Century Medicine, ESSENTIAL PHARMACEUTICALS LLC, Lifeline Scientific, Dr. Franz Köhler Chemie GmbH, Preservation Solutions Inc, OrganOx Limited, XVIVO Perfusion. Market Analysis and Insights